900 – 1,000
The CIMT Annual Meeting is the largest meeting in Europe focused on cancer immunotherapy research and development. Exhibiting at CIMT gives you exposure to international decision-makers in experimental and commercial R&D.
The target audience for this program is basic and clinical investigators from academic institutions, industry and regulatory agencies, including basic and translational researchers, post-doctoral fellows, graduate students, clinicians and health professionals involved in cancer research.
30% academic scientists
35% industry participants
*Projected for CIMT 2018 Annual Meeting